Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
9/30/2025 | $ -230.38M | -275.29% | $ 83.69M |
6/30/2025 | $ -215.18M | -243.46% | $ 88.38M |
3/31/2025 | $ -191.72M | -339.83% | $ 56.42M |
12/31/2024 | $ -172.58M | -316.38% | $ 54.55M |
9/30/2024 | $ -97.14M | -172.17% | $ 56.42M |
6/30/2024 | $ -96.1M | -154.25% | $ 62.3M |
3/31/2024 | $ -74.86M | -92.55% | $ 80.89M |
12/31/2023 | $ -81.36M | -105.69% | $ 76.99M |
9/30/2023 | $ -146.01M | -212.81% | $ 68.61M |
6/30/2023 | $ -151.18M | -248.11% | $ 60.94M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for NURIX THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -80K ] / Revenues [ $ 17.82M ]
(=) OCF % [ -0.45% ]
Minimum
Dec 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |